Data from Pharmawand - Curated by Toby Galbraith - Date added 17 May 2017

Twenty four month data from the BIOSOLVE-II study reveal the long-term safety, efficacy and stability of Biotronik’s Magmaris resorbable magnesium scaffold. Presented during a late-breaking trial session at EuroPCR 2017, the findings demonstrated the continued safety and efficacy of Magmaris at two years, serving as the first results since 95% resorption of the magnesium backbone. The presentation also revealed high procedure success at six months in the BIOSOLVE-III trial.

Findings from both studies are being published concurrently in EuroIntervention. Dr. Haude also presented the pooled six-month data of the BIOSOLVE-II and BIOSOLVE-III studies. The combined results demonstrated consistent and low target lesion failure at 3.3% and no incidence of definite or probable scaffold thrombosis, further confirming the safety and efficacy of Magmaris. Clinical follow-up for BIOSOLVE-III will continue for up to three years.

See-"Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III"- Published on 16 May 2017( ahead of print) -Michael Haude, MD, PhD et.,al. ; on behalf of the BIOSOLVE-II andpBIOSOLVE-III investigators.

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

Visit Allergic Rhinitis

Related Content